MoonLake Immunotherapeutics(MLTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MLTX MoonLake Immunotherapeutics

盘后交易 07-14 18:44:45 EDT

50.86

+1.86

+3.80%

盘后50.95

+0.09+0.18%

18:13 EDT

最高51.04	最低49.00	成交量38.63万
今开49.29	昨收49.00	日振幅4.15%
总市值32.28亿	流通市值14.41亿	总股本6,347万
成交额1,950万	换手率1.36%	流通股本2,834万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MLTX","market":"US","secType":"STK","nameCN":"MoonLake Immunotherapeutics","latestPrice":50.86,"timestamp":1752523200000,"preClose":49,"halted":0,"volume":386332,"hourTrading":{"tag":"盘后","latestPrice":50.95,"preClose":50.86,"latestTime":"18:13 EDT","volume":25031,"amount":1273077.811426,"timestamp":1752531236400},"delay":0,"floatShares":28339172,"shares":63474253,"eps":-2.304156,"marketStatus":"盘后交易","change":1.86,"latestTime":"07-14 18:44:45 EDT","open":49.29,"high":51.035,"low":49,"amount":19503179.812064,"amplitude":0.041531,"askPrice":50.95,"askSize":121,"bidPrice":50.86,"bidSize":20,"shortable":3,"etf":0,"ttmEps":-2.304156,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1752537600000},"marketStatusCode":4,"adr":0,"listingDate":1603166400000,"exchange":"NASDAQ","adjPreClose":49,"preHourTrading":{"tag":"盘前","latestPrice":49,"preClose":49,"latestTime":"09:00 EDT","volume":105,"amount":5244.9999,"timestamp":1752498034368},"postHourTrading":{"tag":"盘后","latestPrice":50.95,"preClose":50.86,"latestTime":"18:13 EDT","volume":25031,"amount":1273077.811426,"timestamp":1752531236400},"volumeRatio":0.635374,"impliedVol":0.6432,"impliedVolPercentile":0.644},"requestUrl":"/m/hq/s/MLTX","defaultTab":"news","newsList":[{"id":"2550567386","title":"Moonlake Immunotherapeutics盘中异动 大幅拉升5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550567386","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550567386?lang=zh_cn&edition=full","pubTime":"2025-07-09 22:40","pubTimestamp":1752072034,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日22时40分，Moonlake Immunotherapeutics股票出现波动，股价大幅拉升5.01%。Moonlake Immunotherapeutics股票所在的生物技术行业中，整体涨幅为1.34%。Moonlake Immunotherapeutics公司简介：MoonLake Immunotherapeutics 是一家处于临床阶段的生物技术公司，致力于推进治疗方案以满足炎症性皮肤和关节疾病领域的未满足需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709224034953c4476&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709224034953c4476&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MLTX","BK4139"],"gpt_icon":0},{"id":"1170178651","title":"默克制药洽谈收购Moonlake ImmunoTherapeutics，估值超30亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1170178651","media":"老虎资讯综合","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170178651?lang=zh_cn&edition=full","pubTime":"2025-06-03 17:25","pubTimestamp":1748942724,"startTime":"0","endTime":"0","summary":"默克制药洽谈收购Moonlake ImmunoTherapeutics。","market":"us","thumbnail":"https://static.tigerbbs.com/03489eed12bb317b593f2ec3ef6a13b2","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/03489eed12bb317b593f2ec3ef6a13b2"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"da071cd660bd035f6d31a3d0f2477fd1","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLTX"],"gpt_icon":0},{"id":"1158982095","title":"美股夜盘｜Credo Technology涨超12%，Q4销售额同比增长近180%；Moonlake涨超21%，消息称默克制药洽谈对其收购","url":"https://stock-news.laohu8.com/highlight/detail?id=1158982095","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158982095?lang=zh_cn&edition=full","pubTime":"2025-06-03 08:12","pubTimestamp":1748909573,"startTime":"0","endTime":"0","summary":"6月3日，美股夜盘时段，Applied Digital续涨3%，该股隔夜暴涨逾48%；Credo Technology涨超12%，第四季度销售额同比增长179.73%。","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"bc1632e7762f403a059671fba9ca12b2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APLD","MLTX","CRDO"],"gpt_icon":0},{"id":"1135933355","title":"市场消息：默克制药洽谈收购瑞士生物科技公司Moonlake ImmunoTherapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=1135933355","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135933355?lang=zh_cn&edition=full","pubTime":"2025-06-03 06:04","pubTimestamp":1748901886,"startTime":"0","endTime":"0","summary":"6月3日，Moonlake ImmunoTherapeutics美股盘后飙涨逾26%！市场消息：默克制药洽谈收购瑞士生物科技公司Moonlake ImmunoTherapeutics，对后者估值超过30亿美元。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0aaf2cd715f8662f0191701c95d27a4a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"市场消息：默克制药洽谈收购瑞士生物科技公司Moonlake ImmunoTherapeutics","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLTX"],"gpt_icon":0},{"id":"2540713894","title":"Moonlake Immunotherapeutics盘中异动 大幅上涨5.05%报40.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540713894","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540713894?lang=zh_cn&edition=full","pubTime":"2025-06-03 03:59","pubTimestamp":1748894379,"startTime":"0","endTime":"0","summary":"北京时间2025年06月03日03时59分，Moonlake Immunotherapeutics股票出现异动，股价快速拉升5.05%。截至发稿，该股报40.98美元/股，成交量29.4232万股，换手率0.46%，振幅4.69%。Moonlake Immunotherapeutics股票所在的生物技术行业中，整体涨幅为1.50%。Moonlake Immunotherapeutics公司简介：MoonLake Immunotherapeutics 是一家临床阶段的生物技术公司，致力于利用纳米体技术开发免疫疾病的新一代的药物，包括炎症性皮肤和关节疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603035940a6f778e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603035940a6f778e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MLTX","BK4139"],"gpt_icon":0},{"id":"2536687729","title":"Moonlake Immunotherapeutics盘中异动 早盘股价大涨5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536687729","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536687729?lang=zh_cn&edition=full","pubTime":"2025-05-19 21:33","pubTimestamp":1747661611,"startTime":"0","endTime":"0","summary":"北京时间2025年05月19日21时33分，Moonlake Immunotherapeutics股票出现波动，股价急速上涨5.58%。Moonlake Immunotherapeutics股票所在的生物技术行业中，整体涨幅为0.23%。Moonlake Immunotherapeutics公司简介：MoonLake Immunotherapeutics 是一家临床阶段的生物技术公司，致力于利用纳米体技术开发免疫疾病的新一代的药物，包括炎症性皮肤和关节疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519213332a48423ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519213332a48423ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MLTX","BK4139"],"gpt_icon":0},{"id":"2536591020","title":"Moonlake Immunotherapeutics2025财年第一财季实现净利润-39.94百万美元，同比减少192.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536591020","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536591020?lang=zh_cn&edition=full","pubTime":"2025-05-19 00:00","pubTimestamp":1747584048,"startTime":"0","endTime":"0","summary":"5月19日，Moonlake Immunotherapeutics公布财报，公告显示公司2025财年第一财季净利润为-39.94百万美元，同比减少192.17%；其中营业收入为0.00美元，每股基本收益为-0.63美元。从资产负债表来看，Moonlake Immunotherapeutics总负债98.68百万美元，其中短期债务1.43百万美元，资产负债比为0.06，流动比率为0.22。机构评级：截至2025年5月19日，当前有14家机构对Moonlake Immunotherapeutics目标价做出预测，其中目标均价为80.43美元，其中最低目标价为65.00美元，最高目标价为108.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000233a6e3a773&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000233a6e3a773&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MLTX"],"gpt_icon":0},{"id":"2535238074","title":"Moonlake Immunotherapeutics盘中异动 股价大跌5.27%报36.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535238074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535238074?lang=zh_cn&edition=full","pubTime":"2025-05-14 23:39","pubTimestamp":1747237140,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日23时39分，Moonlake Immunotherapeutics股票出现异动，股价急速跳水5.27%。截至发稿，该股报36.51美元/股，成交量5.5984万股，换手率0.09%，振幅7.42%。Moonlake Immunotherapeutics股票所在的生物技术行业中，整体跌幅为1.43%。Moonlake Immunotherapeutics公司简介：MoonLake Immunotherapeutics 是一家临床阶段的生物技术公司，致力于利用纳米体技术开发免疫疾病的新一代的药物，包括炎症性皮肤和关节疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514233900a6df251d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514233900a6df251d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MLTX","BK4139"],"gpt_icon":0},{"id":"2534543167","title":"Moonlake Immunotherapeutics盘中异动 临近收盘股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534543167","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534543167?lang=zh_cn&edition=full","pubTime":"2025-05-09 03:53","pubTimestamp":1746734027,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日03时53分，Moonlake Immunotherapeutics股票出现波动，股价急速上涨5.19%。截至发稿，该股报39.55美元/股，成交量39.7297万股，换手率0.63%，振幅7.23%。Moonlake Immunotherapeutics股票所在的生物技术行业中，整体跌幅为1.67%。Moonlake Immunotherapeutics公司简介：MoonLake Immunotherapeutics 是一家临床阶段的生物技术公司，致力于利用纳米体技术开发免疫疾病的新一代的药物，包括炎症性皮肤和关节疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509035347a477227a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509035347a477227a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MLTX"],"gpt_icon":0},{"id":"2533932177","title":"Moonlake Immunotherapeutics盘中异动 大幅下挫5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533932177","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533932177?lang=zh_cn&edition=full","pubTime":"2025-05-07 22:06","pubTimestamp":1746626802,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日22时06分，Moonlake Immunotherapeutics股票出现波动，股价快速下跌5.11%。Moonlake Immunotherapeutics股票所在的生物技术行业中，整体跌幅为0.38%。Moonlake Immunotherapeutics公司简介：MoonLake Immunotherapeutics 是一家临床阶段的生物技术公司，致力于利用纳米体技术开发免疫疾病的新一代的药物，包括炎症性皮肤和关节疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507220642a4757674&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507220642a4757674&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MLTX"],"gpt_icon":0},{"id":"2531057100","title":"Moonlake Immunotherapeutics盘中异动 股价大涨5.00%报42.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531057100","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531057100?lang=zh_cn&edition=full","pubTime":"2025-04-30 23:28","pubTimestamp":1746026919,"startTime":"0","endTime":"0","summary":"北京时间2025年04月30日23时28分，Moonlake Immunotherapeutics股票出现波动，股价大幅拉升5.00%。截至发稿，该股报42.19美元/股，成交量12.0372万股，换手率0.19%，振幅4.83%。Moonlake Immunotherapeutics股票所在的生物技术行业中，整体涨幅为0.82%。Moonlake Immunotherapeutics公司简介：MoonLake Immunotherapeutics 是一家临床阶段的生物技术公司，致力于利用纳米体技术开发免疫疾病的新一代的药物，包括炎症性皮肤和关节疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430232840aa2c7fe3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430232840aa2c7fe3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MLTX","BK4139"],"gpt_icon":0},{"id":"2527198245","title":"Moonlake Immunotherapeutics盘中异动 股价大涨5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527198245","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527198245?lang=zh_cn&edition=full","pubTime":"2025-04-14 22:09","pubTimestamp":1744639752,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日22时09分，Moonlake Immunotherapeutics股票出现波动，股价快速拉升5.27%。Moonlake Immunotherapeutics股票所在的生物技术行业中，整体涨幅为1.40%。其相关个股中，Theratechnologies Inc.、Third Harmonic Bio, Inc.、Artelo Biosciences, Inc.涨幅较大，Artelo Biosciences, Inc.、Aditxt, Inc.、Processa Pharmaceuticals, Inc.较为活跃，换手率分别为526.63%、305.74%、143.82%，振幅较大的相关个股有Artelo Biosciences, Inc.、Theratechnologies Inc.、Metsera, Inc.，振幅分别为48.67%、29.90%、23.79%。Moonlake Immunotherapeutics公司简介：MoonLake Immunotherapeutics 是一家临床阶段的生物技术公司，致力于利用纳米体技术开发免疫疾病的新一代的药物，包括炎症性皮肤和关节疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414220912a458975d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414220912a458975d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MLTX"],"gpt_icon":0},{"id":"1168707494","title":"异动解读 | Moonlake Immunotherapeutics去年大亏3.19亿,股价盘中大跌5%。","url":"https://stock-news.laohu8.com/highlight/detail?id=1168707494","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168707494?lang=zh_cn&edition=full","pubTime":"2025-03-04 05:00","pubTimestamp":1741035628,"startTime":"0","endTime":"0","summary":"生物科技公司Moonlake Immunotherapeutics(MLTX.US)今日盘中大跌5%。\n\n引发该公司股价暴跌的原因很可能是其2024财年表现远逊预期。财报显示,Moonlake去年净利润同比惨淡,亏损高达1.19亿美元,同比减少230.46%。公司目前仍处于无收入阶段,每股亏损1.89美元。\n\n此外,该公司资产负债表状况堪忧,总负债24.54百万美元,资产负债率高达0.20,流动性也相当紧张,流动比率仅为0.22。尽管分析师给予该公司目标价均价在80.92美元,但显然已与当前表现存在差距。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | Moonlake Immunotherapeutics去年大亏3.19亿,股价盘中大跌5%。","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MLTX"],"gpt_icon":0},{"id":"2516665994","title":"Moonlake Immunotherapeutics盘中异动 股价大跌5.06%报39.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516665994","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516665994?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:58","pubTimestamp":1741035513,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时58分，Moonlake Immunotherapeutics股票出现波动，股价快速跳水5.06%。截至发稿，该股报39.65美元/股，成交量17.8904万股，换手率0.28%，振幅6.72%。Moonlake Immunotherapeutics股票所在的生物技术行业中，整体跌幅为0.17%。Moonlake Immunotherapeutics公司简介：MoonLake Immunotherapeutics 是一家临床阶段的生物技术公司，致力于利用纳米体技术开发免疫疾病的新一代的药物，包括炎症性皮肤和关节疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304045833989a64da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304045833989a64da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MLTX"],"gpt_icon":0},{"id":"2516592686","title":"Moonlake Immunotherapeutics2024财年实现净利润-1.19亿美元，同比减少230.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516592686","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516592686?lang=zh_cn&edition=full","pubTime":"2025-03-03 18:00","pubTimestamp":1740996029,"startTime":"0","endTime":"0","summary":"3月3日，Moonlake Immunotherapeutics公布财报，公告显示公司2024财年净利润为-1.19亿美元，同比减少230.46%；其中营业收入为0.00美元，每股基本收益为-1.89美元。从资产负债表来看，Moonlake Immunotherapeutics总负债24.54百万美元，其中短期债务1.37百万美元，资产负债比为0.20，流动比率为0.22。机构评级：截至2025年3月3日，当前有13家机构对Moonlake Immunotherapeutics目标价做出预测，其中目标均价为80.92美元，其中最低目标价为65.00美元，最高目标价为108.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303180036abe5da37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303180036abe5da37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MLTX"],"gpt_icon":0},{"id":"2514861722","title":"Moonlake Immunotherapeutics盘中异动 股价大涨5.01%报42.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514861722","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514861722?lang=zh_cn&edition=full","pubTime":"2025-02-27 03:42","pubTimestamp":1740598954,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日03时42分，Moonlake Immunotherapeutics股票出现波动，股价急速上涨5.01%。截至发稿，该股报42.77美元/股，成交量40.5569万股，换手率0.64%，振幅6.69%。Moonlake Immunotherapeutics股票所在的生物技术行业中，整体跌幅为0.46%。Moonlake Immunotherapeutics公司简介：MoonLake Immunotherapeutics 是一家临床阶段的生物技术公司，致力于利用纳米体技术开发免疫疾病的新一代的药物，包括炎症性皮肤和关节疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227034234a2553be3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227034234a2553be3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MLTX","BK4139"],"gpt_icon":0},{"id":"1159720103","title":"MoonLake 2024年第四季度每股亏损$(0.72) 超出预期$(0.60)，预计截至2026年底现金、现金等价物和短期可出售债务证券余额为4.48亿美金","url":"https://stock-news.laohu8.com/highlight/detail?id=1159720103","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159720103?lang=zh_cn&edition=full","pubTime":"2025-02-26 20:42","pubTimestamp":1740573763,"startTime":"0","endTime":"0","summary":"MoonLake报告季度每股亏损$，比分析师的共识预期$多出20%。这比去年同期每股亏损$增加了620%。以上内容来自Benzinga Earnings专栏，原文如下：MoonLake  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 20 percent. This is a 620 percent decrease over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"MoonLake 2024年第四季度每股亏损$(0.72) 超出预期$(0.60)，预计截至2026年底现金、现金等价物和短期可出售债务证券余额为4.48亿美金","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLTX"],"gpt_icon":0},{"id":"2509235033","title":"Moonlake Immunotherapeutics盘中异动 早盘股价大涨5.04%报46.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509235033","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509235033?lang=zh_cn&edition=full","pubTime":"2025-02-06 00:18","pubTimestamp":1738772289,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日00时18分，Moonlake Immunotherapeutics股票出现异动，股价快速上涨5.04%。截至发稿，该股报46.34美元/股，成交量9.2296万股，换手率0.15%，振幅4.58%。Moonlake Immunotherapeutics股票所在的生物技术行业中，整体涨幅为1.36%。Moonlake Immunotherapeutics公司简介：MoonLake Immunotherapeutics 是一家临床阶段的生物技术公司，致力于利用纳米体技术开发免疫疾病的新一代的药物，包括炎症性皮肤和关节疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206001809a23a9438&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206001809a23a9438&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MLTX","BK4139","KTTA"],"gpt_icon":0},{"id":"2508229881","title":"Moonlake Immunotherapeutics盘中异动 股价大跌5.00%报43.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508229881","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508229881?lang=zh_cn&edition=full","pubTime":"2025-02-04 03:36","pubTimestamp":1738611404,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日03时36分，Moonlake Immunotherapeutics股票出现波动，股价大幅下挫5.00%。截至发稿，该股报43.69美元/股，成交量12.7106万股，换手率0.20%，振幅6.04%。Moonlake Immunotherapeutics股票所在的生物技术行业中，整体跌幅为0.11%。Moonlake Immunotherapeutics公司简介：MoonLake Immunotherapeutics 是一家临床阶段的生物技术公司，致力于利用纳米体技术开发免疫疾病的新一代的药物，包括炎症性皮肤和关节疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020403364496172687&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020403364496172687&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MLTX"],"gpt_icon":0},{"id":"2505277159","title":"Moonlake Immunotherapeutics盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505277159","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505277159?lang=zh_cn&edition=full","pubTime":"2025-01-21 23:25","pubTimestamp":1737473139,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日23时25分，Moonlake Immunotherapeutics股票出现波动，股价快速拉升5.00%。截至发稿，该股报46.00美元/股，成交量9.8481万股，换手率0.16%，振幅4.22%。Moonlake Immunotherapeutics股票所在的生物技术行业中，整体涨幅为1.29%。Moonlake Immunotherapeutics公司简介：MoonLake Immunotherapeutics 是一家临床阶段的生物技术公司，致力于利用纳米体技术开发免疫疾病的新一代的药物，包括炎症性皮肤和关节疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121232540986e3dc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121232540986e3dc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MLTX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.moonlaketx.com","stockEarnings":[{"period":"1week","weight":0.0022},{"period":"1month","weight":0.1094},{"period":"3month","weight":0.404},{"period":"6month","weight":0.058},{"period":"1year","weight":0.0504},{"period":"ytd","weight":-0.0951}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.037},{"period":"3month","weight":0.168},{"period":"6month","weight":0.0743},{"period":"1year","weight":0.1207},{"period":"ytd","weight":0.0641}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"MoonLake Immunotherapeutics.是一家于2020年8月13日注册的开曼群岛公司，该公司是一家临床阶段的生物技术公司，致力于推进变革性疗法，以解决炎症性皮肤和关节疾病方面的重大未满足需求。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.024369},{"month":2,"riseRate":0.4,"avgChangeRate":0.077053},{"month":3,"riseRate":0.6,"avgChangeRate":0.026866},{"month":4,"riseRate":0.2,"avgChangeRate":-0.112596},{"month":5,"riseRate":0.4,"avgChangeRate":0.086858},{"month":6,"riseRate":0.8,"avgChangeRate":0.175967},{"month":7,"riseRate":0.6,"avgChangeRate":0.067205},{"month":8,"riseRate":0.5,"avgChangeRate":0.086405},{"month":9,"riseRate":0.5,"avgChangeRate":0.009386},{"month":10,"riseRate":0.5,"avgChangeRate":-0.025877},{"month":11,"riseRate":0.6,"avgChangeRate":0.046361},{"month":12,"riseRate":0.6,"avgChangeRate":0.103362}],"exchange":"NASDAQ","name":"MoonLake Immunotherapeutics","nameEN":"MoonLake Immunotherapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MoonLake Immunotherapeutics(MLTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供MoonLake Immunotherapeutics(MLTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"MoonLake Immunotherapeutics,MLTX,MoonLake Immunotherapeutics股票,MoonLake Immunotherapeutics股票老虎,MoonLake Immunotherapeutics股票老虎国际,MoonLake Immunotherapeutics行情,MoonLake Immunotherapeutics股票行情,MoonLake Immunotherapeutics股价,MoonLake Immunotherapeutics股市,MoonLake Immunotherapeutics股票价格,MoonLake Immunotherapeutics股票交易,MoonLake Immunotherapeutics股票购买,MoonLake Immunotherapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MoonLake Immunotherapeutics(MLTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供MoonLake Immunotherapeutics(MLTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}